iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California.
Revenue (Most Recent Fiscal Year) | $591.84M |
Net Income (Most Recent Fiscal Year) | $-113.29M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 8.06 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 51.13 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -13.94% |
Net Margin (Trailing 12 Months) | -14.06% |
Return on Equity (Trailing 12 Months) | -90.03% |
Return on Assets (Trailing 12 Months) | -8.52% |
Current Ratio (Most Recent Fiscal Quarter) | 5.02 |
Quick Ratio (Most Recent Fiscal Quarter) | 4.88 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 6.25 |
Inventory Turnover (Trailing 12 Months) | 12.85 |
Book Value per Share (Most Recent Fiscal Quarter) | $2.90 |
Earnings per Share (Most Recent Fiscal Quarter) | $-0.32 |
Earnings per Share (Most Recent Fiscal Year) | $-3.08 |
Diluted Earnings per Share (Trailing 12 Months) | $-2.93 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Devices |
Common Shares Outstanding | 32.13M |
Free Float | 31.91M |
Market Capitalization | $5.30B |
Average Volume (Last 20 Days) | 0.51M |
Beta (Past 60 Months) | 1.41 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 0.68% |
Percentage Held By Institutions (Latest 13F Reports) | -- |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |